JJ, N., M, B., RR, B., RG, M., EJ, P., AR, S., & NA, E. (2025). Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement from the American Diabetes Association. Diabetes care, 48(2), 177. https://doi.org/10.2337/dci24-0091
Chicago Style (17th ed.) CitationJJ, Neumiller, Bajaj M, Bannuru RR, McCoy RG, Pekas EJ, Segal AR, and ElSayed NA. "Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement from the American Diabetes Association." Diabetes Care 48, no. 2 (2025): 177. https://doi.org/10.2337/dci24-0091.
MLA (9th ed.) CitationJJ, Neumiller, et al. "Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement from the American Diabetes Association." Diabetes Care, vol. 48, no. 2, 2025, p. 177, https://doi.org/10.2337/dci24-0091.